1:39
WBFO Reporter Emyle Watkins interviews Dr. Brian Clemency about a new NIH-funded COVID-19 treatment study at the University at Buffalo.
In simple terms, this means if you tested positive in the last week, you could be eligible to be part of a national study involving drugs that may treat mild to moderate COVID.
Dr. Brian Clemency, a professor of emergency medicine at UB, says researchers want to know how effective certain treatments, specifically monoclonal antibodies, might be in treating the disease. What’s unique about this study, is that you don’t have to be high risk for COVID to participate. The study opens the door to patients who wouldn’t traditionally get these medications, to see how well they work.